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REVIEW
NF-B signaling pathways in mammalian
and insect innate immunity
Neal Silverman and Tom Maniatis1
Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA
Innate immunity
Innate immunity is the first line of defense against in-
fectious microorganisms. The innate immune system re-
lies on germ line-encoded pattern recognition receptors
(PRRs) to recognize pathogen-derived substances
(Janeway 1989). Activation of the innate immune system
through these receptors leads to the expression of a vast
array of antimicrobial effector molecules that attack mi-
croorganisms at many different levels. The innate im-
mune system appeared early in evolution, and the basic
mechanisms of pathogen recognition and activation of
the response are conserved throughout much of the ani-
mal kingdom (Hoffmann et al. 1999).
In contrast to innate immunity, the adaptive immune
system generates antigen-specific receptors, antibodies,
and T-cell receptors by somatic cell DNA rearrange-
ment. These receptors, found only in higher eukaryotes,
recognize specific pathogen-encoded proteins. Mammals
have a complex immune response, which relies on com-
munication between the innate and adaptive arms of the
immune system. The innate immune response generates
a costimulatory signal, which is required in combination
with antigen-specific recognition to activate T-cells and
the adaptive immune system. Antigen-specific recogni-
tion in the absence of costimulation can lead to anergy
rather than activation (Janeway 1989). Thus, the activa-
tion of an antigen-specific response is coupled to infec-
tion through the innate immune system.
Insects have a very potent innate immune response
that effectively combats a broad spectrum of pathogens.
For example, Drosophila can withstand, and clear, bac-
terial burdens that, relative to their size, would be lethal
to mammals (Hoffmann and Reichhart 1997). Induction
of innate immunity in both mammals and insects leads
to the activation of similar effector mechanisms, such as
stimulation of cell-based phagocytic activity and expres-
sion of antimicrobial peptides (Hoffmann et al. 1999). For
example, Drosophila produce a wide range of potent an-
timicrobial peptides in response to infection by fungi or
bacteria (Hoffmann and Reichhart 1997). Induction of
the antimicrobial peptides is regulated at the level of
transcription, and they are expressed primarily in the fat
body, the insect liver analog.
Recent studies have revealed striking similarities in
the signaling pathways used by humans and flies to ac-
tivate their innate immune responses. In both cases, in-
fection leads to the activation of Toll-like receptors
(TLRs), which in turn initiate intracellular signaling cas-
cades that culminate in the activation of NF-B/Rel fam-
ily transcription factors. In this review, we discuss re-
cent advances in understanding the signaling pathways
in mammalian and Drosophila innate immunity, with
emphasis on the mechanisms by which NF-B/Rel fam-
ily proteins are activated.
Innate immune signaling pathways
Drosophila
Drosophila has two independent immune signaling
pathways, both of which lead to the activation of NF-B
transcription factors. One pathway responds primarily to
fungal and gram positive bacterial infection (Fig. 1),
while the other responds to lipopolysaccharide (LPS)
treatment or infection by gram-negative bacteria (Fig. 2)
(Lemaitre et al. 1996, 1997). The antifungal pathway re-
quires components of the Toll signaling pathway, most
of which are also required during dorsoventral patterning
of the embryo (Belvin and Anderson 1996). Induction of
the Toll/antifungal pathway leads to the activation of
two Drosophila NF-B homologs, called Dorsal and Dif,
resulting in the production of antifungal peptides such as
Drosomycin. Dorsal is also required in early embryogen-
esis for the Toll-dependent patterning of the dorsoven-
tral axis. Dif is required for antifungal immunity in the
adult fly, whereas in larvae either Dif or Dorsal is suffi-
cient for the immune response (Manfruelli et al. 1999;
Meng et al. 1999; Rutschmann et al. 2000a).
By contrast, the LPS-inducible antibacterial pathway
requires the third Drosophila NF-B homolog, Relish,
which activates the expression of genes encoding anti-
bacterial peptides such as Diptericin (Hedengren et al.
1999; Rutschmann et al. 2000b). Relish is synthesized as
an NF-B precursor protein that is cleaved and activated
in response to bacterial infection or LPS treatment
(Sto¨ven et al. 2000). Interestingly, some antimicrobial
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peptides, such as Cecropin, can be activated by either
pathway and are thought to have both antibacterial and
antifungal activities (Lemaitre et al. 1996; Ekengren and
Hultmark 1999). In any case, one mechanism used to
direct the transcription apparatus to distinct sets of an-
timicrobial genes in response to different pathogens is
the activation of different members of the NF-B family.
In Drosophila, infection also leads to the activation of
the JNK (Sluss et al. 1996) and JAK/STAT signaling path-
ways (Lagueux et al. 2000). The function of the JNK path-
way in immunity has not been established whereas the
JAK/SAT pathway is necessary for the induction of a
number of complement-like proteins that have recently
been shown to function by opsonizing gram-negative
bacteria and promoting their phagocytosis (Lagueux et
al. 2000; Levashina et al. 2001). Very little is known
about the response of the insect immune system to other
classes of pathogens, for example, virus, spirochetes or
plasmodia.
Mammals
The mammalian innate immune system responds to a
plethora of microbial-derived substances including mi-
crobial cell wall components such as LPS, peptidylgly-
cans, and lipoproteins (Krutzik et al. 2001). The innate
immune system can also be activated by bacterial DNA
(Krieg 1996) or double-stranded RNA, the latter of which
Figure 2. The Drosophila antibacterial signaling pathway. In
this model the signaling pathway is activated by LPS through
unidentified receptor(s) and leads to Relish cleavage. Down-
stream of the receptors, this signaling pathway bifurcates. One
part leads to activation of the Drosophila IKK complex, which
then phosphorylates Relish. The other part functions through
the caspase Dredd and leads to the cleavage of phosphorylated
Relish. At present it is not known whether Dredd acts directly
or indirectly to cleave Relish. The IMD protein may function in
one or both of these pathways. (N) Amino-terminal domain; (C)
carboxy-terminal domain.
Figure 1. The Drosophila Toll/antifungal signaling pathway.
This model highlights current understanding of the Toll signal-
ing pathway as it functions during the immune response. The
pattern recognition receptors that recognize fungal pathogens
are unknown, but they are believed to activate a serine protease
cascade, culminating in the cleavage of the Toll ligand Spätzle.
Ligand binding to Toll leads to the recruitment of two proteins,
the adaptor Tube and the kinase Pelle. Recruitment of Pelle is
thought to cause its activation and disassociation from Toll.
Activated Pelle may then activate, directly or indirectly, a Cac-
tus kinase that is responsible for signaling the proteasome-me-
diated degradation of Cactus. Currently, the biochemical steps
between Pelle and Cactus degradation remain undetermined,
and the Cactus kinase has not yet been identified.
Silverman and Maniatis
2322 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on July 7, 2016 - Published by genesdev.cshlp.orgDownloaded from 
is common to many viruses (Mogensen and Paludan
2001). The TLRs play a central role in the recognition of
many of these immunostimulatory molecules and are
probably responsible for the recognition of most types of
pathogens. In response to these signals, the TLRs acti-
vate signaling pathways that culminate in the expression
of antimicrobial molecules (proteins, peptides, and reac-
tive oxygen and nitrogen intermediates), cytokines, and
costimulatory molecules (Fig. 3) (Medzhitov et al. 1997;
Thoma-Uszynski et al. 2001; Zhang and Ghosh 2001).
Thus, activation of the innate immune system immedi-
ately slows infection and activates other aspects of the
immune system, primarily T-cells. The TLRs activate a
number of signaling pathways including the JNK/AP-1
pathway, proapoptotic caspase cascades, and NF-B in-
ducing pathways (Medzhitov et al. 1997; Muzio et al.
1998; Aliprantis et al. 1999, 2000). These pathways are
responsible for activating the appropriate effector
mechanisms and signaling molecules.
The innate immune system plays a critical role in
regulating the decision between the two types of mam-
malian immune responses, referred to as Type 1 and
Type 2 responses. The Type 1 response functions to com-
bat small intracellular pathogens such as bacteria
whereas the Type 2 response combats larger extracellu-
lar pathogens such as helminths. The particular array of
signaling molecules expressed by antigen presenting
cells (APCs) determines whether a Type 1 or Type 2 re-
sponse is activated. The expression of these signaling
molecules, cytokines and costimulatory molecules, is
controlled by the types of pathogens sensed by APCs
through PRR, such as the TLRs. Thus, in addition to its
role in activating the adaptive immune system, the in-
nate immune response plays a central role in coordinat-
ing the particular type of adaptive immune response so
that it will be most effective in combating the pathogens
presented (Pulendran et al. 2001).
These two types of responses in mammals bear some
similarity to the twoDrosophila immunity pathways. In
Drosophila, the two immune responses are activated by
two different types of pathogens and are specifically
suited to combat the pathogen presented. The insect an-
tibacterial pathway is activated by pathogens that would
also activate a Type 1 response in mammals. On the
other hand, the insect Toll/antifungal pathway responds
best to infection by fungal pathogens, which form large
hyphal structures. Similar stimuli, such as helminths
and certain fungi, activate a Type 2 response in mam-
mals (Hoffmann et al. 1999; Pulendran et al. 2001). Per-
haps the similarity between the two types of immune
responses, found in both insects and mammals, is due to
conservation of the mechanisms used to distinguish be-
tween broad classes of pathogens. Although some of the
effector mechanisms are quite different, the recognition
and subsequent signaling events required for activating
these pathways may be very similar throughout the ani-
mal kingdom. The identification and characterization of
the receptors and signaling pathways necessary for acti-
vation of innate immunity in response to a variety of
pathogens, in both flies and humans, will clarify these
issues.
Mechanisms of NF-B activation
Much has been learned recently about innate immunity
in both mammals and flies, and knowledge from these
two systems has been highly complementary (see Table
1). The most significant common feature of innate im-
Figure 3. The LPS signaling pathway in mammals. In this
model LPS is recognized by a complex of three proteins; CD14,
MD-2, and TLR4. TLR4 activates the intracellular signaling cas-
cade by recruiting MyD88 and IRAK to the membrane. IRAK
associates with the receptor complex transiently; once released
IRAK can associate with and activate TRAF6. The TRAF6
RING finger, in combination with Ubc13 and Uev1A, mediates
the K63-extended polyubiquitination of TRAF6 itself. The
TAK1/TAB1/TAB2 complex is activated by its association with
ubiquitinated TRAF6. Interestingly, the TAK1-associated pro-
tein TAB2 translocates from the membrane fraction to the cy-
toplasmic fraction upon treatment with IL-1. Once activated,
the TAK1 complex phosphorylates and activates the IKK com-
plex. The activated IKK complex then phosphorylates IB,
leading to its ubiquitination and degradation by the proteasome.
NF-B and innate immune signaling pathways
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munity throughout the animal kingdom is the central
role of the NF-B/Rel family of transcriptional activator
proteins (Karin and Ben-Neriah 2000). In unstimulated
cells NF-B/Rel family proteins exist as hetero- or ho-
modimeric proteins that are sequestered in the cyto-
plasm by virtue of their association with a member of
the IB family of inhibitor proteins. An astonishing
number of extracellular signals can trigger distinct signal
transduction pathways, each of which culminates in the
destruction of IB proteins. These signal transduction
pathways lead to the activation of the IB kinase, or IKK
(for review, see Karin and Ben-Neriah 2000), and the sub-
sequent phosphorylation of serine residues within the
N-terminal destruction box of IB proteins (i.e., S32 and
S36 of IB) (Ghosh et al. 1998). Phospho-IB is then
recognized by the -TrCP-containing SCF ubiquitin li-
gase complex, leading to its ubiquitination and degrada-
tion by the proteasome (Karin and Ben-Neriah 2000). In-
terestingly, the active -TrCP–SCF complex that func-
tions in NF-B signaling is modified by the ubiquitin-
like protein Nedd8 (Read et al. 2000). The degradation of
IB unmasks the nuclear localization signal of the NF-
B/Rel family protein, leading to its nuclear transloca-
tion and binding to enhancers or promoters of target
genes.
The fly IB protein is known as Cactus, and by analogy
with IB regulation, Cactus degradation is thought to
be controlled by signal-dependent serine phosphoryla-
tion. However, the exact sequences required for Cactus
degradation have not been definitively established (Berg-
mann et al. 1996; Reach et al. 1996). Moreover, the ki-
nase responsible for signal-dependent Cactus phosphory-
lation has not been identified. Two IKK-related kinases
are encoded in the Drosophila genome, although neither
has been shown to be required for the Toll-induced Cac-
tus phosphorylation and degradation (see below for more
details) (Fig. 4). Like IB, the ubiquitin/proteasome path-
way is required for signal-dependent Cactus degradation.
Mutants in slimb, the Drosophila -TrCP homolog, ex-
hibit defects in dorsoventral patterning (Spencer et al.
1999), and Cactus degradation can be blocked by protea-
some inhibitors (N. Pandey, N. Silverman and T. Mani-
atis, unpubl.). Thus, it appears that the mechanisms in-
volved in the activation of theDrosophilaDorsal and Dif
proteins during early development and antifungal immu-
nity are highly similar to those required for the activa-
tion of NF-B in mammals.
NF-B/Rel family proteins can also be sequestered in
the cytoplasm as large precursors (the mammalian p105
and p100 proteins and the Drosophila Relish protein).
Table 1. Comparison of innate immune signaling proteins in Drosophila and mammals
Drosophila Mammals
Pattern recognition receptors
Non-signaling GNBP (3) CD14, MD-2
LPS ? TLR4
PG, LP, zymosan ? TLR2
Flagellin ? TLR5
Bacterial DNA ? TLR9
Orphan Receptors 18 wheeler, dTLR3-9 Other TLRs
Cytokines and receptors
TNF/TNFR TNF-like/TNFR-likea TNF/TNFR1&2
Spa¨tzle/Toll Spa¨tzle/Toll ?
Il-1/IL-1R-related None IL-1/IL-1R (8)
Intracellular signaling components
Adapters Tube, dMyD88 MyD88, Tollip
Pelle-like Kinases Pelle IRAK (4)
TRAF dTRAF1-3 TRAF1-6
MAP3K dTAK1, dMEKK TAK1, TAB1&2, NIK, MEKK1-3
Atypical PKC DaPKC PKC and , p62
RIP-like Proteins IMD RIP
NF-B components
IBs Cactus IB, , , 
IB Kinases
IKK/ DMIKK (ird5) IKK, 
IKK DmIKK (kenny) IKK/NEMO/IKKAP
IKK-like DmIKK/dIK2 IKK/i, TBK/NAK/T2K
NF-B precursors Relish p105, p100
and products Relish N & C p50, p52
NK-B subunits Dorsal, Dif RelA/p65, RelB, c-Rel
Both known and putative innate immune signaling proteins are categorized into pattern recognition receptors, cytokines and their
receptors, intracellular signaling components, and NF-B related kinases and transcription factors. The number of orthologs per
genome are indicated in parentheses.
aThe Drosophila TNFR-like predicted gene contains a TNFR-like cysteine-rich extracellular domain but does not include a TNFR-
related intracellular domain.
Silverman and Maniatis
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The N termini of these proteins contain the DNA bind-
ing and dimerization domains (the Rel homology do-
main), whereas the C termini contain a series of ankyrin
repeat sequences similar to those present in IB proteins.
Thus, these precursor proteins are sequestered in the cy-
toplasm by virtue of their covalent attachment to an
IB-like inhibitory domain. The C-terminal domain can
be removed by proteolysis, either constitutively or, at
least in the case of p100 and Relish, in response to sig-
nals (see discussion below).
IB kinases
Key components of the NF-B signaling pathways are the
IB kinases (IKKs) (Karin and Ben-Neriah 2000). An IB
kinase capable of specifically phosphorylating serines 32
and 36 of IB was originally identified as a high-mo-
lecular-weight complex (∼700kD) (Chen et al. 1996; Lee
et al. 1998). Subsequently, two catalytic subunits (IKK/
1and IKK/2) and a structural subunit of this complex
(IKK/NEMO/IKKAP) were identified and cloned (Karin
and Ben-Neriah 2000). More recently, two related ki-
nases known as IKK/IKKi and TBK/NAK/T2K were
characterized and found to be in complexes distinct from
that of IKK// (Fig. 4) (Peters and Maniatis 2001).
The IKK// complex can be activated by a variety of
stimuli, including inducers of the innate immune re-
sponse, such as infection by virus or treatment with LPS
(O’Connell et al. 1998; Chu et al. 1999; Fischer et al.
1999; Hawiger et al. 1999). Activation of the complex
involves the phosphorylation of two serine residues lo-
cated in the “activation loop” within the kinase domain
of IKK or IKK. Certain MAP3 kinases (MEKK1,
MEKK2, MEKK3, and NIK) are capable of phosphorylat-
ing these serines in vitro, and activating NF-B in trans-
fection experiments (Karin and Ben-Neriah 2000). In ad-
dition, dominant negative mutants of either MEKK1 or
NIK kinase can inhibit NF-B activation in response to
certain inducers. However, it has been difficult to estab-
lish definitively a role in NF-B activation for either of
these kinases under physiological conditions. For ex-
ample, IKK activation and IB degradation occur nor-
mally in embryonic fibroblasts from NIK knockout mice
(Yin et al. 2001). Curiously, although the NIK−/− cells
display normal NF-B DNA-binding activity in response
to numerous stimuli, they exhibit weak activation of
NF-B-dependent genes specifically in response to lym-
photoxin- receptor (LTR) signaling. This can now be
explained by the observation that NIK is an IKK kinase
required specifically for signal-dependent p100 process-
ing (see below for more details) (Matsushima et al. 2001;
Xiao et al. 2001). Thus, the phosphorylation of IKK by
NIK observed in vitro does not appear to be physiologi-
cally significant.
Similarly, although MEKK1 can phosphorylate both
IKK and IKK in vitro, mekk1−/− mouse embryonic fi-
broblasts (MEFs) display normal NF-B activation in re-
sponse to TNF (Yujiri et al. 2000). By contrast, MEKK3,
which can also phosphorylate IKK in vitro, is required
for TNF-induced NF-B activation.mekk3−/− MEFs ex-
hibit a greatly decreased level of IKK activation, IB deg-
radation, and NF-B activation in response to TNF
(Yang et al. 2001).
Alternatively, in some cases the IKK complex may be
activated simply by virtue of its recruitment to the re-
ceptor complex at the cell membrane (Inohara et al.
2000). This idea is based in part on the observation that
IKK, which is essential for IKK activation, specifically
interacts with the TNF receptor-associated protein RIP
(Devin et al. 2000; Poyet et al. 2000; Zhang et al. 2000),
and that the IKK complex is recruited to the activated
receptor via the IKK–RIP interaction. In addition, IKK
and IKK are both capable of autophosphorylation and
cross-phosphorylation of their activation domains (Del-
hase et al. 1999; O’Mahony et al. 2000). Finally, forced
Figure 4. Phylogenetic comparison of IKK-related kinases.
Phylogram of a branch-and-bound search using bootstrap analy-
sis of aligned IKK sequences. Gaps were removed with Lineup;
data were processed using PAUPDisplay and visualized as a
midpoint rooted phylogram. Numbers indicate occurrence of
nodes (out of 100 reiterations) during bootstrap analysis. Two
subgroups of IKK are clearly distinguishable. One contains the
IKK and IKK genes (and a related protein from the oyster,
Crassostrea gigas); the other clade contains the IKK-related
genes. TheDrosophila IKKs include DmIKK, clearly a member
of the IKK subgroup, and DmIKK which is not truly in either
subgroup, although within the kinase domain it is most similar
to IKK. (m) Mouse; (r) rat; (h) human; (o) oyster; (Dm) Dro-
sophila melanogaster.
NF-B and innate immune signaling pathways
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multimerization of the IKK// complex can lead to its
activation (Poyet et al. 2000). Thus, the recruitment of
the kinase complex to the intracellular domains of vari-
ous receptors, leading to its increased local concentra-
tion, may, under some circumstances, be sufficient to
activate the kinase.
Whatever the mechanisms of activation, it is clear that
the IKK// complex is required for NF-B activation in
response to most NF-B inducers. In fact, ikk−/− mice
display fetal liver apoptosis, much like the NF-B p65
subunit knockout mice (Q. Li et al. 1999; Z. Li et al.
1999; Tanaka et al. 1999). Moreover, similar to the p65
knockout mice (Rosenfeld et al. 2000; Alcamo et al.
2001), when the ikk−/− mice are crossed into a tnfr1−/−
mouse the liver apoptosis is suppressed. Thus, liver
apoptosis in both cases is TNF-dependent. Finally,
ikk−/− MEFs do not degrade IB or activate NF-B in
response to various stimuli including TNF and LPS.
Interestingly IKK also plays a role in NF-B activation,
as ikk−/− cells still have residual IKK activity and NF-B
transcriptional response. However, IKK/ double
knockout cells have no NF-B response (Li et al. 2000).
Based on the observation that IKK can activate IKK, it
was proposed that IKK actually functions as an IKK-
kinase, phosphorylating IKK (O’Mahony et al. 2000).
However, this proposal is based primarily on overexpres-
sion experiments and is not supported by any of the phe-
notypes observed in IKK−/− mice.
Remarkably, IKK, but not IKK, appears to play a role
in keratinocyte differentiation and proliferation (Hu et
al. 1999; Takeda et al. 1999). ikk−/− mice have a skin
abnormality caused by the continued proliferation of
stem cells and the lack of keratinocyte differentiation.
Although the target of IKK in keratinocyte differentia-
tion is unknown, it does not appear to be in the NF-B
pathway, as none of the NF-B knockout mice display a
similar skin phenotype. In addition, neither the IKK
kinase activity nor the NF-B pathway are required for
the normal keratinocyte differentiation (Hu et al. 2001).
Rather, it appears that IKK controls production of a
soluble factor that induces keratinocyte differentiation.
Another difference between IKK and IKK, which is
discussed in more detail below, is that IKK, but not
IKK, is required for the phosphorylation-dependent pro-
teolytic processing of the p100 precursor of p52, which
plays a critical role in B cell maturation and formation of
secondary lymphoid organs (Senftleben et al. 2001).
The phenotype of IKK-deficient mice is consistent
with the phenotype of IKK-deficient cells (Yamaoka et
al. 1998). These mice display fetal liver apoptosis similar
to that observed in IKK and p65 knockout mice. Fur-
thermore, ikk−/− MEFs are sensitive to TNF and cannot
activate NF-B in response to TNF or LPS (Rudolph et
al. 2000). Interestingly, the human disease incontinentia
pigmenti (IP) appears to be caused by IKK mutations
(Smahi et al. 2000). This is a dominant X-linked disease
with perinatal lethality in males. In heterozygous fe-
males, cells expressing only the mutant IKK gene (be-
cause of X chromosome inactivation) die shortly after
birth. Cells from patients, or mice, with homozygous
IKK mutations show no detectable IKK protein, they
do not activate NF-B in response to TNF, and they are
more sensitive to TNF-induced cell death (Makris et al.
2000; Schmidt-Supprian et al. 2000; Smahi et al. 2000).
The role of the other two IKK-related kinases, IKK/i
and TBK1/T2K/NAK, is less clear. Transfection experi-
ments with wild type and dominant negative mutants of
recombinant TBK1 suggested that TBK1 functions in the
NF-B pathway through TANK and TRAF2. However,
the signaling pathways that rely on the TBK1–TANK–
TRAF complex remain to be identified. The same kinase,
termed NAK (NF-B Activating Kinase), was proposed to
function upstream of the IKK complex and to activate
IKK by direct phosphorylation of the activation loop
serine residues, during PMA and growth factor-mediated
signaling (for review, see Peters and Maniatis 2001).
On the other hand, deletion of this gene in mice, re-
ferred to as T2K, suggests a role in TNF signaling. The
phenotype of t2k−/− mice is very similar to that of the
IKK and p65 knockouts, as they display severe TNF-
induced embryonic liver degeneration and apoptosis.
Thus, T2K appears to be a key component in the TNF
signaling pathway in liver cells. t2k−/− MEFs exhibit de-
creased activation of some, but not all, NF-B responsive
genes in response to TNF or IL-1. However, t2k−/−
MEFs display normal induction of IKK activity, IB deg-
radation, and NF-B DNA binding activity (Peters and
Maniatis 2001). These observations suggest that T2K
functions after IB degradation. For example, T2K
could function to directly or indirectly activate the tran-
scriptional activity of the p65 subunit of NF-B. Other
possible explanations are that T2K is required for a sepa-
rate TNF-inducible pathway, such as the JNK pathway,
or that T2K is required for the activation of a certain
subset of NF-B dimers. Those genes whose transcrip-
tion requires this particular dimer would thus be most
affected by the T2K deletion.
In vitro, both TBK1/T2K/NAK and IKK can phos-
phorylate the N-terminal regulatory domain of IB.
This phosphorylation occurs only on serine 36, even
though residues 32 and 36 must be modified to induce
IB degradation. However, in response to PMA stimu-
lation, IKK associates with an unidentified kinase ac-
tivity that phosphorylates serines 32 and 36 of IB. Al-
though the identity of the IKK-associated IKK is un-
known, it was demonstrated that it is neither IKK nor
IKK. In Jurkat cells expression of dominant negative
IKK blocks PMA- and TCR-mediated, but not TNF-
induced, NF-B activation. These data argue that in
mammals an alternate IKK complex exists that is re-
sponsible for IB phosphorylation and degradation in
response to a certain subset of stimuli, for example, T-
cell activation (Peters and Maniatis 2001).
As mentioned above, Drosophila has two IKK related
genes. One, known as DmIKK, is a member of the IKK/
TBK subfamily of IKKs and its function remains un-
known. The other Drosophila IKK relative is known as
DmIKK (or DLAK) and is required for the antibacterial
immune signaling pathway (Kim et al. 2000a; Silverman
et al. 2000). Although DmIKK is most similar to hIKK
Silverman and Maniatis
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(and thus its name), it is in a subfamily of its own, as it
has little homology with either IKK or IKK in its C-
terminal half (Fig. 4). DmIKK was shown to be part of a
high-molecular-weight Drosophila IKK complex that
also contains DmIKK, a homolog to hIKK/NEMO/IK-
KAP (Silverman et al. 2000). The DmIKK complex is ac-
tivated by LPS treatment, directly phosphorylates Rel-
ish, and is essential for Relish activation (cleavage) and
the induction of antibacterial peptide gene transcription.
These observations led to the proposal that once acti-
vated by LPS, the DmIKK complex phosphorylates Rel-
ish, which is then cleaved by an unidentified protease
(Fig. 2) (Silverman et al. 2000).
DmIKK has also been shown to phosphorylate Cac-
tus (Kim et al. 2000a) and the sites of phosphorylation
have been mapped to the N-terminal regulatory domain
of Cactus (Silverman et al. 2000). However, the signifi-
cance of this modification is not clear. Mutations in the
DmIKK or DmIKK genes, ird5 or kenny, respectively,
cause defects in antibacterial immunity, but have rela-
tively little effect on antifungal immunity and dorsoven-
tral patterning (Rutschmann et al. 2000b; Lu et al. 2001).
Curiously, Lu et al. report that the ird5 mutants have a
slight dorsoventral phenotype showing dorsalization in
0.5% of embryos laid by ird5 mothers. Thus, it is pos-
sible that DmIKK plays a role in the Toll pathway in a
redundant manner with other unidentified kinases.
Proteolytic processing of NF-B/Rel precursor proteins
Mammalian p100 and p105 proteins
The p50 and p52 subunits of NF-B are generated by
proteolytic processing of p105 and p100 precursors, re-
spectively. In both cases the rel homology domain is lo-
cated at the N terminus of the precursor, whereas the
C-terminal IB-like domain functions as a covalently at-
tached IB inhibitor protein. Both precursors are pro-
cessed in vivo and in vitro by a mechanism requiring
ubiquitination and partial degradation by the 26S protea-
some (Chen and Maniatis 1998; Karin and Ben-Neriah
2000). The regulation of p105 and p100 processing ap-
pears to play important biological roles, as mice lacking
the precursor protein but able to express the mature pro-
tein display specific defects in the immune and inflam-
matory pathways (Ishikawa et al. 1997, 1998).
Studies of the sequence requirements for p105 process-
ing revealed that p105 molecules containing ∼110 amino
acids beyond the C terminus of p50 are accurately pro-
cessed, and a glycine-rich region (GRR), located just up-
stream from the p50 C terminus, is essential for cleavage
(Lin and Ghosh 1996). Although the GRR was initially
thought to be both necessary and sufficient for p50 gen-
eration (Lin and Ghosh 1996), subsequent studies re-
vealed that additional sequences containing ubiquitina-
tion sites downstream from the GRR are also necessary
for p105 processing (Fig. 5) (Orian et al. 1999).
A unique feature of p105 processing is the limited deg-
radation by the proteasome. It is possible that this is
accomplished by a mechanism in which the C terminus
of the precursor protein enters the proteasome and is
degraded processively. In this model the GRR functions
as a stop signal and protects p50 from degradation (Orian
et al. 1999). This model is further supported by the re-
cent observation that ATP-dependent proteases, includ-
ing the proteasome, degrade substrates processively from
a degradation signal (Lee et al. 2001). However, more
studies are required to prove this model. The detailed
mechanism by which NF-B precursors are processed by
the proteasome is controversial. A number of studies
have clearly demonstrated a precursor/product relation-
ship for both proteins (Chen and Maniatis 1998; Karin
and Ben-Neriah 2000). However, it has also been sug-
gested that p105 and p100 are not the precursors of p50
and p52, but function primarily as IBs in the cytoplasm.
Instead, p50 and p52 were proposed to be generated by a
cotranslational processing mechanism (Lin et al. 1998;
Heusch et al. 1999; Lin et al. 2000).
Regardless of the processing mechanism, the most im-
portant question is whether it is regulated. Regulated
processing is difficult to demonstrate for p50 because
expression of the p105 gene is itself regulated by NF-B.
Thus, increases in p50 could be due to either increased
processing or increased p105 expression. An important
insight into the mechanism of p105 processing/degrada-
tion was provided by the observation that the C termi-
nus of p105 is phosphorylated in response to signals that
activate NF-B (Heissmeyer et al. 1999; Orian et al.
2000). Several different kinases have been shown to in-
teract with and phosphorylate p105, including TPL-2
(Belich et al. 1999) and the IKKs (Heissmeyer et al. 1999;
Orian et al. 2000). However, recent experiments with
TPL-2 knockout mice have shown that TPL-2 is not re-
quired for LPS-dependent activation of NF-B (Dumitru
et al. 2000). Thus, the connection between TPL-2 and
p105 remains in question.
IKK and IKK interact with and directly phosphory-
late the C terminus of p105 (Heissmeyer et al. 1999,
2001). The phosphorylated serine residues are found in a
conserved DSXXXDS destruction box motif, which is
recognized by the same SCF–TrCP ubiquitin ligase
complex that recognizes the destruction box in IB.
Similar conclusions were reached in an independent
study in which the phosphorylation and ubiquitination
of p105 were stimulated by cotransfection p105 and con-
stitutively active IKK (Orian et al. 2000). However, the
consequence of this phosphorylation is controversial.
Heissmeyer et al. (1999) concluded that the signal-depen-
dent phosphorylation of p105 results in its degradation
rather than processing. By contrast, Orian et al. (2000)
argue that the phosphorylation of p105 by IKK can lead
to processing (Ciechanover et al. 2001). Thus, in spite of
considerable effort, there is as yet no definitive demon-
stration of a signal-dependent induction of p105 process-
ing.
A clearer picture has emerged for the regulated pro-
cessing of p100 (Xiao et al. 2001). This study also sheds
light on the role of the MAP3 kinase NIK in the NF-B
signaling pathway. Relatively little p52 is produced in
most cell types, even though p100 is present, so it ap-
NF-B and innate immune signaling pathways
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pears that p100 processing is tightly regulated. The p100
(nfkb2) knockout results in defects in B cell function and
abnormalities in peripheral lymphoid organs. Remark-
ably, a similar phenotype is also observed in alympho-
plasia (aly) mice, which carry a mutation in the gene
encoding NIK (Shinkura et al. 1999). Because of this
similarity, Sun and coworkers systemically analyzed the
role of NIK in p100 activation (Xiao et al. 2001). They
found that processing of transfected p100 increases dra-
matically when active NIK is cotransfected and that this
increase is enhanced by cotransfection of the LTR.
Moreover, this processing was not observed in spleno-
cytes from the alymouse. In contrast to earlier studies of
constitutively processed p100 (Heusch et al. 1999), a
clear p100 precursor/p52 product relationship was ob-
served in pulse chase experiments. Thus, at least in the
regulated processing of p100, p52 is generated by a NIK-
dependent post-translational processing mechanism.
Although NIK was proposed to be the direct upstream
kinase for p100 (Xiao et al. 2001), more recent studies
have shown that NIK functions in p100 processing by
activating IKK. Specifically, NIK-induced p100 process-
ing was shown to require IKK, and recombinant IKK
was found to be a more efficient p100 kinase than NIK
(Senftleben et al. 2001). Xiao et al. (2001) also demon-
strated that phosphorylation of the C terminus of p100
leads to its polyubiquitination. Thus, it seems likely that
LTR signaling activates NIK, which in turn activates
IKK, which then phosphorylates p100, leading to its
ubiquitination and processing by the proteasome. This
conclusion is consistent with the observation that nik−/−
and ikk−/− cells do not respond to LTR activation
(Matsushima et al. 2001; Yin et al. 2001). Thus, p100
provides a clear example of signal-dependent processing
of NF-B precursors.
Drosophila Relish protein
Like p105 and p100, Relish is a bipartite protein with an
N-terminal NF-B-like Rel homology domain and a C-
terminal IB-like ankyrin repeat domain (Dushay et al.
1996). In unstimulated cells the Relish C-terminal IB
module sequesters its own N-terminal NF-B module in
the cytoplasm. Upon activation of the antibacterial sig-
naling pathway, Relish is proteolytically cleaved and the
N-terminal NF-B module translocates into the nucleus,
while the stable C-terminus remains in the cytoplasm.
Thus, the regulation of Relish is unique among the NF-
B precursor proteins. Whereas processing of p100 and
p105 is a proteasome-dependent event that does not
leave a stable C-terminal domain, Relish cleavage is not
mediated by the proteasome and results in a stable C
Figure 5. NF-B precursor proteins frommammals andDrosophila. The mammalian precursor proteins, p100 and p105, are processed
in a ubiquitin–proteasome-dependent manner. Approximate cleavage sites are marked with orange arrows. p105 processing (and/or
degradation) is controlled by two regions, the constitutive central ubiquitin region and the inducible C-terminal IKK/–TrCP-depen-
dent phosphorylation and ubiquitination element. p100 processing is stimulated by NIK in an IKK-dependent mechanism. Response
to NIK requires the NRS, a probable IKK phosphorylation site. Constitutive processing of p100 is inhibited by the processing
inhibitory domain (PID), which colocalizes with a predicted death domain (DD). Relish cleavage is stimulated by LPS treatment and
requires caspase proteases, not the proteasome. A potential caspase cleavage site (CCS) is found in the linker domain of Relish.
Silverman and Maniatis
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terminus. In fact, Relish processing may be controlled by
a caspase protease and is stimulated by the Drosophila
IKK complex (see below). It is interesting to speculate
that p105 and p100may be processed by a similar mecha-
nism in response to inducers that have yet to be identi-
fied.
Rel phosphorylation
Another level of regulation of NF-B/Rel activity in both
mammals and Drosophila is the phosphorylation of Rel
proteins. A number of studies have shown that the sig-
nal-dependent activation of NF-B requires both IB
degradation and Rel protein phosphorylation, and these
two steps can be uncoupled (Schmitz et al. 2001). For
example, in the absence of Cactus, the nuclear translo-
cation of Dorsal remains signal dependent (Bergmann et
al. 1996; Drier et al. 2000), and this correlates with the
signal-dependent phosphorylation of Dorsal (Drier et al.
1999). Although multiple serine residues are phosphory-
lated, when serine 317 is substituted by alanine a signifi-
cant embryonic phenotype is observed, and Dorsal does
not translocate to the nucleus.
In mammals the NF-B p65 protein has a protein ki-
nase A phosphorylation site on serine 276, and phos-
phorylation of this residue is required for efficient bind-
ing to the transcriptional activator protein CBP. Accord-
ing to a model proposed by Ghosh and colleagues, PKA is
associated with the IB/NF-B complex in the cyto-
plasm in an inactive form, and signal-dependent degra-
dation of IB allows PKA to phosphorylate serine 276
(Zhong et al. 1997). Phosphorylation of S276 induces a
conformational change in p65, exposing a phosphoryla-
tion-independent CBP interaction site and creating a
phosphorylation-dependent interaction with the Kix do-
main of CBP (Zhong et al. 1998).
The TNF-dependent phosphorylation of serine 529
has also been shown to increase the transcriptional ac-
tivity of p65, and this stimulation is not at the level of
nuclear translocation or DNA binding. Recently, casein
kinase II was implicated in the TNF-dependent phos-
phorylation of serine 529 (Wang and Baldwin 1998; Wang
et al. 2000). Similar to the situation with PKA, IB pro-
tects p65 from phosphorylation by constitutively active
CKII, but signal-dependent degradation of IB exposes
the p65 phosphorylation site to CKII activity. CKII was
shown to associate with p65 in vivo, and this association
decreased upon TNF induction. Moreover, CKII phos-
phorylates p65 at serine 529 in vitro, and inhibitors of
CKII block phosphorylation and transcriptional activa-
tion in vivo (Wang et al. 2000). Thus, once released from
IB, at least two kinases, PKA and CKII, phosphorylate
p65, at different serine residues, to increase its transcrip-
tional activity.
Other kinases have also been shown to act on p65. For
example, IL-1 treatment has been shown to induce the
phosphorylation of p65, and this phosphorylation re-
quires phosphatidylinositol-3 kinase and Akt (Sizemore
et al. 1999). Also, Akt has been implicated in Ras-in-
duced NF-B activation (Madrid et al. 2000). In these
studies, Akt signaling required IKK and serines 529 and
536 of p65 (Madrid et al. 2001). Similarly, overexpression
of IKK led to the phosphorylation of p65 at serine 536
(Sakurai et al. 1999). Serine residues 529 and 536 were
shown to be required for the activation of the p65 fusion
proteins by activated Akt or treatment with IL-1
(Madrid et al. 2001). Thus, activated PI3K and Akt appear
to induce NF-B-dependent transcription by activating
p65 rather than by promoting the degradation of IB
and nuclear translocation of NF-B.
As mentioned above, in mouse embryonic fibroblasts
lacking functional T2K, IB phosphorylation and deg-
radation occur in response to TNF, but NF-B reporter
genes are not activated, suggesting the possibility that
phosphorylation of Rel proteins by T2K is required for
transcriptional activity. In addition, inactivation of the
mouse gene encoding the glycogen synthase kinase-3
(GSK-3) has no effect on the degradation of IB and
nuclear translocation of p65 in response to TNF, yet
causes decrease in NF-B DNA-binding activity and a
defect in NF-B transcriptional activity (Hoeflich et al.
2000). Thus, GSK-3 and T2K appear to act downstream
of IB degradation, possibly at the level of Rel protein
activation. Another possible explanation for the NF-B
phenotype observed in the GSK and T2K knockout MEFs
is that these kinases may play a role in the activation of
only a certain subset of Rel dimers. For example, they
could promote the processing of Rel protein precursors
(p100 and p105), similar to the function of NIK in p100
processing (Xiao et al. 2001; Yin et al. 2001). In any case,
there is ample evidence to support the idea that p65
phosphorylation is critical for full NF-B activation, and
this activation can be uncoupled functionally from IB
phosphorylation and degradation.
Inducible phosphorylation of Rel proteins appears to
function at many different levels, including inducing
conformational changes in the activation domain, in-
creasing DNA binding activity, and promoting associa-
tion with transcriptional coactivator proteins such as
CBP/p300 (Schmitz et al. 2001). The overall function ap-
pears to be in the integration of signaling pathways to
activate distinct Rel proteins in response to different sig-
nals.
Toll-like receptors
The TLRs are characterized by an extracellular domain
containing a number of leucine-rich repeats (LRRs), a
single pass transmembrane domain, and an intracellular
signaling domain, referred to as a TIR (Toll/IL-1R/Resis-
tance) domain (Wilson et al. 1997; Zhang and Ghosh
2001). The TIR domain is common to the TLRs, the IL-
1R family, and a number of plant genes that are required
for host defense signaling. The IL-1R family is distinct
from the TLR family because of a dissimilar extracellular
domain, which consists of Ig domains. In all these recep-
tors, the TIR domain mediates activation of intracellular
signaling pathways. At least 10 TLRs are found in the
mammalian genome (Aravind et al. 2001; Zhang and
NF-B and innate immune signaling pathways
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Ghosh 2001), whereas Drosophila encodes 9 (Tauszig et
al. 2000).
In mammals, TLR4 is required for LPS-mediated sig-
naling and is believed to directly recognize LPS. LPS is a
potent activator of innate immunity, and excessive ex-
posure to LPS, or endotoxin, causes serious pathological
effects (Beutler 2000). The mechanism of LPS signaling
remained a mystery until the discovery of the human
TLRs and the finding that hTLR4 is necessary for LPS
signaling. The clearest demonstration of the role of
hTLR4 in LPS signaling was provided by the positional
cloning of lps, a mutation that causes hyporesponsive-
ness to LPS in mice. lps mutants carry loss-of-function
mutations in the mTLR4 gene (Poltorak et al. 1998). Fur-
thermore, TLR4 appears to directly bind to LPS. Lipid A
is the active component of LPS and deacetylated lipid A
is immunostimulatory in murine but not human sys-
tems. Two groups recently demonstrated that expression
of mTLR4, but not hTLR4, enabled recognition and sig-
naling in response to deacetylated lipid A (Lien et al.
2000; Poltorak et al. 2000). In addition to TLR4, two
other extracellular proteins are involved in LPS recogni-
tion. CD14, a GPI anchored protein, has long been
known to bind to LPS and is required for LPS signaling
(Moore et al. 2000). MD-2 interacts with extracellular
domain of TLR4 and is necessary for LPS signaling
(Shimazu et al. 1999; Schromm et al. 2001). Also, Ulev-
itch and colleagues recently demonstrated that LPS is
found in close proximity to TLR4, CD14, and MD-2 (da
Silva Correia et al. 2001). This argues that TLR4, CD14,
and MD-2 bind to LPS, possibly in a tetrameric complex.
Interestingly, CD14 and TLR4 have also been implicated
in the immune recognition of proteins encoded by viral
pathogens such as RSV (Kurt-Jones et al. 2000).
Drosophila Toll, the founding member of the TLR
family, is required for both development and immunity.
During early embryonic patterning, Toll is required for
establishing the dorsoventral axis. Toll is activated by
the spatially and temporally restricted activation of its
putative ligand, Spätzle (Belvin and Anderson 1996).
This is believed to be accomplished by the correspond-
ingly restricted activation of a serine protease cascade
consisting of the products of the nudel, gastrulation de-
fective, snake, and easter genes (LeMosy et al. 1999,
2001; Dissing et al. 2001). Activation of this protease
cascade is regulated by the products of the windbutel
and pipe genes. Interestingly, pipe is the only one of the
12 dorsal group genes expressed in a spatially restricted
manner, on the ventral side of the embryo. The spatially
restricted expression of pipe is therefore thought to be
the key signal activating the entire cascade in the correct
location to establish ventral cell fates (Sen et al. 1998).
The pipe gene product is a heparin-sulfotransferase, and
it has been proposed to create a heparin-modified proteo-
glycan that is required for local activation of the protease
cascade. Activation of Toll, by Spätzle, stimulates a sig-
naling pathway culminating in the activation of theDro-
sophila Dorsal protein and the expression of ventral spe-
cific genes such as twist and snail (Belvin and Anderson
1996).
As mentioned earlier the Toll signaling pathway, in-
cluding Spätzle, is also responsible for the antifungal im-
munity in insects (Lemaitre et al. 1996). However, none
of the genes that function upstream of Spätzle during
development are necessary for the antifungal immune
response. A mutation in a Drosophila serpin gene (serine
protease inhibitor), known as necrotic, has been shown
to cause constitutive activation of the antifungal Toll
pathway (Levashina et al. 1999). Thus, it appears that a
different serine protease cascade is activated by fungal
infection and leads to the processing of Spätzle. The
identity of these proteases and the mechanism of their
activation remain unknown. Thus, inDrosophila, Toll is
indirectly required for immune recognition of pathogens.
Analysis of the completeDrosophila genome sequence
identified nine different Toll-related receptors: Toll,
18wheeler, and dTLR3–9 (Tauszig et al. 2000). It is pos-
sible that one or more of theseDrosophila TLRs function
as an LPS receptor, analogous to the role of TLR4 in
mammals. In fact, mutants in the TLR receptor
18wheeler have some defects in antibacterial immune
signaling. Specifically, the antimicrobial peptide gene at-
tacin is not fully activated in response to Escherichia
coli infection. However, induction of the other antibac-
terial peptides, such as diptericin, occurs at near wild-
type levels in 18wheeler mutants. Therefore, 18w is not
strictly required for the antibacterial immune response
and cannot be the sole LPS receptor (Williams et al.
1997). The possible immune function of eight Dro-
sophila TLRs was investigated recently (Tauszig et al.
2000). Remarkably, potentially dominant activated ver-
sions of these TLRs did not mimic antibacterial signal-
ing, suggesting that none of the dTLRs are the LPS re-
ceptor. One possible explanation for this result is that
two dTLRs must heterodimerize to create the fully func-
tional LPS receptor, similar to TLR2 and TL6 in the rec-
ognition of peptidoglycan (Ozinsky et al. 2000). Studies
with dominant negative receptors, and ultimately ge-
netic experiments with TLR mutants, are necessary to
definitively determine the role of the Drosophila TLRs
in the insect antibacterial immune response. One extra-
cellular protein involved in LPS signaling in Drosophila
is DGNBP1 (Drosophila gram-negative binding protein),
which was shown to bind to LPS. DGNBP1 does not
have transmembrane or intracellular domain and, like
CD14, is held at the membrane by a GPI anchor. Over-
expression of DGNBP1 potentiates LPS signaling while
antibody interference with DGNBP1 inhibits LPS signal-
ing. This argues that DGNBP1 plays an important role in
the antibacterial immune response; however it cannot be
responsible for activating intracellular signaling path-
ways (Kim et al. 2000b).
In mammals TLR2 is thought to be directly involved
in recognizing cell wall components from gram positive
bacteria and spirochetes, peptidoglycans, and lipopro-
teins (Krutzik et al. 2001; Zhang and Ghosh 2001). Also,
TLR9 is required for the recognition of bacterial DNA
(Hemmi et al. 2000). Bacterial DNA is a potent immune
stimulatory molecule and is specifically recognized be-
cause of its unmethylated CpG dinucleotides (Krieg
Silverman and Maniatis
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1996). Recently, TLR5 has been shown to mediate the
induction of the immune response by the bacterial
flagellin protein (Hayashi et al. 2001). However, the
mechanisms of TLR-mediated recognition remain
unclear; the interactions of TLR2, TLR5, or TLR9 with
any of their putative ligands have yet to be demon-
strated biochemically. Further complicating our under-
standing of TLR-mediated recognition, a recent paper
demonstrated that TLR2, but not TLR4, is responsible
for the recognition of LPS from Porphyromonas gingiva-
lis bacteria, which has a slightly different structure com-
pared to that of E. coli-derived LPS (Hirschfeld et al.
2001).
It will be interesting to discover if any of the mamma-
lian TLRs have protein ligands, likeDrosophila Toll, and
if any of the Drosophila TLRs can directly recognize
pathogen-derived molecules. An alternative model is
that the Toll-like receptors recognize ligands that con-
tain both protein and non-protein components. For ex-
ample, the protein MD-2 was shown to associate with
the ectodomain of TLR4, and to be required for LPS sig-
naling in mammalian tissue culture (Shimazu et al.
1999; Schromm et al. 2001). Thus, MD-2 may be consid-
ered a “co-ligand” with LPS for hTLR4. In Drosophila,
the biochemical requirements for Spätzle–Toll interac-
tion have not yet been determined. It is possible that
Spätzle binding to Toll requires an unidentified (non-
protein) molecule. Perhaps the pipe heparin–sulfotrans-
ferase creates such a molecule or modifies Spätzle in a
manner that is required for Toll binding. This possibility
is consistent with the proposal “that the domain of pipe
expression establishes . . . the spatial limits of binding of
processed Spätzle to Toll” (Morisato 2001).
Hirschfeld et al. (2001) also demonstrated that signal-
ing by the mammalian TLR2 and TLR4 lead to the acti-
vation of overlapping but non-identical genes. For ex-
ample, TLR2 activation causes the expression of IL-1,
but not IFN, whereas TLR4 activation leads to the ex-
pression of both IL-1 and IFN. This clearly demon-
strates that activation of different TLRs by different
types of pathogens promotes the generation of non-iden-
tical signaling pathways. These signals will then tune
the immune system to activate the appropriate effector
responses. It is not clear how the different TLRs can
activate different sets of genes. In the studies published
to date, the signaling pathways activated by various
TLRs have been found to be very similar (Medzhitov et
al. 1998; Yang et al. 1999). However, it is now clear that
more careful analyses of the differences between these
receptor-activated signaling pathways are required. Pos-
sibly, the TLR2 and TLR4 activate different NF-B spe-
cies, or the differences may arise from the other path-
ways that are activated in conjunction with NF-B. In
fact, a new report suggests that the TLR4 signaling, but
not the TLR2 signaling, uses the p38 MAPK pathway
(Rabehi et al. 2001). In this way, the appropriate response
would be activated by each TLR in response to different
pathogens.
The TLRs have been implicated in the cell surface rec-
ognition of many pathogen-derived substances. How-
ever, the mechanisms by which foreign substances are
recognized within the cell are poorly understood. For ex-
ample, virus infection is a potent activator of pro-inflam-
matory signaling pathways leading to the activation of
NF-B, JNK, and IRF proteins (Maniatis et al. 1998).
Within the cell, double-stranded RNA is thought to be
the pathogen-derived substance that triggers the antivi-
ral response. A potential PRR for double-stranded RNA
is the dsRNA-dependent protein kinase, PKR. However,
evidence for a role of this kinase in NF-B activation is
controversial. Two studies have reported that pkr−/−
MEFs are unresponsive to virus- and dsRNA-mediated
induction of the IFN- (Yang et al. 1995; Chu et al. 1999),
yet pkr−/− mice respond normally (Yang et al. 1995; Abra-
ham et al. 1999). Furthermore, another group, using
similar pkr−/− cells, reported normal dsRNA induced IB
degradation and NF-B activation while phosphorylation
of eIF-2, a known target of PKR, is not observed (Ior-
danov et al. 2001; B. Magun, pers. comm.). Therefore,
they conclude that PKR is required for dsRNA-mediated
inhibition of host cell protein synthesis but is not nec-
essary for activation of NF-B and immune-inducible
genes in response to dsRNA or virus infection (Iordanov
et al. 2001). At present the reason for this discrepancy is
not understood.
Other possible candidates for dsRNA receptors are the
NOD proteins (Bertin et al. 1999; Inohara et al. 1999;
Hlaing et al. 2001; Ogura et al. 2001b). The NOD genes
encode cytosolic proteins that contain a LRR domain,
similar to that found in the extracellular domains of the
TLRs, an ATPase domain related to APAF-1/CED4, and
one or more CARD domains. At least 20 NOD-like genes
have been identified in the human genome sequence
(Inohara et al. 2001). Through the CARD domain, NOD1
and NOD2 can interact with RIP2/RICK and activate
NF-B (Bertin et al. 1999; Inohara et al. 1999; Ogura et al.
2001b). Perhaps the LRR domain of the NOD genes is
involved in the recognition of dsRNA and/or other in-
tracellular pathogen-derived substances. In fact, Nunez
and colleagues have shown that NOD1 or NOD2 expres-
sion confers responsiveness to (presumably intracellular)
LPS in a TLR4-independent manner (Inohara et al. 2001).
Thus, the NOD genes may encode a family of PRRs that
function within the cell to recognize substances released
from intracellular pathogens. Interestingly, mutations in
the NOD2 gene are linked to susceptibility to Crohn’s
disease, an inflammatory bowel disease (Hugot et al.
2001; Ogura et al. 2001a). Three independent NOD2
mutations were found associated with different Crohn’s-
susceptible families. One of these alleles is a one-base-
pair insertion that causes premature termination,
truncating the last LRR. When overexpressed both
the wild-type and mutant NOD2 genes activate an
NF-B reporter. However, when expressed at lower
levels only the wild-type, but not the mutant, NOD2
can mediate the LPS-induced activation of NF-B (Ogura
et al. 2001a). These findings suggest a link between
Crohn’s disease, which is thought to have both en-
vironmental and genetic determinants, and innate im-
munity.
NF-B and innate immune signaling pathways
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Receptor proximal signaling events
Much current research in both the mammalian and Dro-
sophila innate immunity fields is focused on the mecha-
nisms of TLR-mediated activation of IKK complexes and
NF-B. The literature on this subject is confusing and
sometimes contradictory, as a firm understanding of the
biochemistry involved has been difficult. In the remain-
ing section of this review, we summarize the proteins
that play a role in these intracellular signaling pathways
and discuss their likely function. The TNFR1 pathway is
the best-studied mammalian NF-B activation pathway.
Although TNFR1 signaling is not activated directly by
pathogens, we include it in our discussion for compari-
son to the TLR pathways. Also, the IL-1 and LPS sig-
naling pathways are discussed together because they are
very similar.
TNF
TNFR1 is activated through a ligand-induced reorgani-
zation of a trimeric receptor complex that brings to-
gether intracellular death domains (Chan et al. 2000a).
This conformational change may cause the dislocation
of a protein, known as silencer of death domain or
SODD, which normally functions to silence the TNFR1
in the absence of ligand (Jiang et al. 1999). This is fol-
lowed by the assembly of a receptor proximal signaling
complex, which is nucleated by the death domain bind-
ing protein TRADD. TRADD in turn recruits TRAF2
and RIP (Fig. 6) (Chan et al. 2000b). RIP is a death do-
main-containing kinase required for TNF-mediated
NF-B activation (Ting et al. 1996; Kelliher et al. 1998).
However, the kinase domain of RIP is dispensable for
NF-B activation. Instead, complementaion of a RIP-de-
ficient cell line requires the intermediate domain of RIP,
which lies between the kinase domain and the death
domain (Ting et al. 1996). The death domain is required
for the binding of RIP to TRADD. Numerous studies
with dominant negative TRAF2 proteins have shown
that it is important for TNF signaling. TRAF2 knock-
out cells exhibit reduced and delayed activation of NF-
B-dependent gene expression and also show deficient
IKK activation (Arch et al. 1998). This intermediate phe-
notype observed in the traf2−/− cells probably reflects
redundancy between TRAF2 and another TRAF gene,
possibly TRAF5 (Tada et al. 2001).
Two recent studies examined the roles of TRAF2 and
RIP in TNF signaling. One study, Devin et al. (2000),
demonstrated that the IKK complex is activated by re-
cruitment to the activated TNFR1 complex in a TRAF2-
dependent manner. Activation of receptor-associated
IKK complexes requires RIP (Devin et al. 2000). In an-
other study, Zhang et al. (2000) also found that the IKK
complex is recruited to TNFR1 in a ligand-dependent
manner. In contrast to the findings of Devin et al., they
show that RIP can directly interact with IKK/NEMO.
The data in Zhang et al. (2000) also suggest contradictory
to Devin et al. that the IKK complex associated with the
TNFR1 is not activated. The reason for this discrepancy
is not understood.
IMD
In Drosophila, there is no evidence for a TNFRI-like sig-
naling complex, although the Drosophila genome en-
codes a TNF-like molecule and a receptor with a
TNFR-like extracellular domain. However, this receptor
does not contain a cytoplasmic domain homologous to
either TNFR. The role of these TNF-like factors in Dro-
sophila immunity remains unknown (Aravind et al.
2001).
Interestingly, a RIP-like molecule does play an impor-
tant role in the insect antibacterial immune response. As
mentioned earlier, gram-negative bacterial infection, or
LPS treatment, activates a signaling cascade that culmi-
nates in the proteolytic activation of Relish. Genetic
screens have identified five genes required for this sig-
naling pathway: ird5 (DmIKK), kenny (DmIKK),
dTAK1, Dredd (see below), and immunodeficient (imd)
(Lemaitre et al. 1995; Elrod-Erickson et al. 2000; Leulier
et al. 2000; Rutschmann et al. 2000b; Lu et al. 2001;
Vidal et al. 2001). Recently, imdwas cloned and found to
Figure 6. TNFR1 signaling. In this model of TNFR1 signaling,
the IKK complex is activated while associated with the receptor.
The IKK complex is recruited to the receptor in a TNF-depen-
dent manner. This recruitment requires TRAF2 and may also
involve the interaction between IKK and RIP. TRAF2 is
thought to activate the IKK complex via a ubiquitin-dependent
signaling pathway. The TRAF2/ubiquitin signaling complex
may lead to the activation of MEKK3, although this has yet to
be demonstrated. RIP is also likely to play a role in activation of
the IKK complex, possibly by interacting with MEKK3 (Yang et
al. 2001). Once activated, the IKK complex phosphorylates IB
on serines 32 and 36, leading to its proteasome-mediated deg-
radation.
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encode a protein with homology to the mammalian RIP
protein. The imd protein includes a death domain most
similar to that of RIP and another domain with weak
similarity to the intermediate domain of RIP. Unlike
RIP, imd does not contain a kinase domain. By analogy
to mammalian RIP, IMD is predicted to function in a
receptor proximal role, possibly associating with the yet-
to-be identified LPS receptor. Overexpression of IMD
leads to activation of the antibacterial peptide genes (S.
Naitza and P. Georgel, pers. comm.).
TLR signaling
In mammals, the first intracellular event following LPS
or IL-1 treatment is the recruitment of the adaptor pro-
tein MyD88 to TLR4 or IL-1R complexes (Wesche et al.
1997; Medzhitov et al. 1998). MyD88 contains a TIR do-
main and a death domain. MyD88 interacts with TLR4
via a homotypic TIR connection, and it recruits the ki-
nase IRAK (IL-1 receptor associated kinase) to the recep-
tor complex via a homotypic death domain interaction.
Another protein, called Tollip, may also be involved in
recruiting IRAK to the IL-1R complex and in keeping the
unliganded IL-1R complex from signaling (Burns et al.
2000). MyD88 is required for IL-1 and IL-18 signaling and
activation of NF-B (Adachi et al. 1998). MyD88−/− mice
and macrophages were also found to be unresponsive
to LPS. However, MyD88−/− macrophages still acti-
vate NF-B DNA-binding activity in response to LPS,
albeit with delayed kinetics (Kawai et al. 1999). This
surprising finding suggests that LPS signaling, presum-
ably through TLR4, requires MyD88 for its full biologi-
cal response, but that macrophages do not absolutely re-
quire MyD88 to degrade IB and activate NF-B. The
mechanism by which LPS activates NF-B in a MyD88-
independent manner remains unknown. One possibility
is that the LPS-induced NF-B response observed in
MyD88-deficient cells reflects NOD signaling rather
than TLR4 signaling. Another possibility is that TLR4
uses another adapter molecule in addition to MyD88. It
is also not clear why MyD88 knockout mice and mac-
rophages are unresponsive to LPS but can still activate
NF-B.
Pelle/IRAK
Similar to RIP, the kinase activity of IRAK is not re-
quired for NF-B activation, although IRAK is required
for optimal IL-1– and LPS-induced signaling. For ex-
ample, an IRAK-deficient cell line, which is defective in
IL-1 signaling, can be complemented by a kinase-defi-
cient IRAK transgene. In other experiments transfection
of a kinase-dead IRAK gene leads to the activation of
NF-B (Knop and Martin 1999; X. Li et al. 1999; Masch-
era et al. 1999). In fact, IL-1- mediated NF-B activation
requires the N terminus (death domain and “undefined
domain”) and the C terminus, but not the central kinase
domain of IRAK (Li et al. 2001). The conclusion that
kinase activity is not required for IRAK-dependent NF-
B activation is tempered by the existence of four IRAK-
like genes, and the fact that IRAK2 can associate with
the IL-1R complex. Thus, during LPS or IL-1 signaling,
the kinase activity of IRAK could be supplied by IRAK or
one of its three homologs. IRAK-deficient mice and cells
(macrophages and fibroblasts) are defective in IL-1– and
LPS-induced NF-B activation. They exhibit weaker and
slower IKK activation, NF-B DNA binding activity,
gene activation, and cytokine production (Kanakaraj et
al. 1998; Thomas et al. 1999; Swantek et al. 2000). How-
ever, NF-B is still activated, albeit more slowly and
weakly, in the irak−/− cells. Presumably one or more of
the other IRAK-like proteins can function in a partially
redundant manner during IL-1- and LPS-induced signal-
ing (Muzio et al. 1997; Wesche et al. 1999; Aravind et al.
2001). The association of IRAK with the receptor is
thought to be transient. Once activated, IRAK is released
from the receptor, and is thought to bind to and activate
TRAF6. The IRAK/TRAF6 complex can then activate
downstream targets (Cao et al. 1996; Ishida et al. 1996).
Toll signaling in Drosophila requires the protein Tube
and the IRAK-like kinase Pelle. The receptor proximal
events in Drosophila Toll signaling differ somewhat
from those of mammalian TLR signaling. Genetic ex-
periments demonstrated that Tube functions upstream
of Pelle (Drier and Steward 1997), suggesting that Tube is
the link between the receptor and the kinase. Thus,
Tube can be viewed as an adapter analogous, but not
homologous, to the mammalian MyD88 protein. Inter-
estingly, a Drosophila MyD88-like gene is found in the
Drosophila genomic DNA database, but its role in Toll
signaling or other dTLR-mediated pathways has not been
established (Aravind et al. 2001).
Activation of Toll by Spätzle leads to the recruitment
of Tube to the membrane, possibly by direct interaction
between Toll and Tube (Shen and Manley 1998; Towb et
al. 1998). Tube interacts with Pelle through the homo-
typic death domain, although this binding occurs prefer-
entially with inactive Pelle (Edwards et al. 1997; Xiao et
al. 1999). Inactive Pelle has also been shown to interact
with the Toll cytoplasmic domain (Shen and Manley
1998). Shen and Manley have proposed that signal-in-
duced Pelle activation leads to the phosphorylation of
Toll, Tube, and Pelle itself, allowing the dissociation of
the Toll–Tube–Pelle membrane proximal complex that
forms immediately upon receptor activation. The disso-
ciation of the receptor complex would allow Pelle, and
possibly Tube, to disengage from the receptor following
activation, and proceed into the cytoplasm where it is
required to mediate signal transduction. However, sig-
nal-dependent Pelle activation has yet to be demon-
strated. Unlike IRAK-dependent signaling, the kinase ac-
tivity of Pelle is required for Toll signaling (Shelton and
Wasserman 1993). It has also been suggested that Tube
has an additional function in the Toll pathway, acting as
a co-activator with Dorsal in the nucleus (Norris and
Manley 1995, 1996).
Interestingly, the Toll cytoplasmic domain and Tube
have also been shown to interact with Filamin (also
known as ABP-280), a component of the cytoskeleton
(Edwards et al. 1997). Interestingly, the Toll–Filamin in-
NF-B and innate immune signaling pathways
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teraction is reduced by missense mutations in the Toll
signaling domain that prevent signaling (N. Silverman
and T. Maniatis, unpubl.). Filamin may serve as scaffold
protein for the assembly of the signaling components of
the Toll pathway. Filamin has also been implicated in
NF-B activation in mammals. For example, a Filamin-
deficient melanoma cell line is unresponsive to TNF or
TLR activation, and complementation with Filamin ex-
pression restores some signaling to these cells (Leonardi
et al. 2000).
TRAFs
In mammals, key components in various NF-B activat-
ing pathways are the TRAF proteins (Arch et al. 1998).
As mentioned above TRAF2 plays a critical role in TNF
signaling while TRAF6 is essential for IL-1 and LPS sig-
nal transduction. A variety of experiments have impli-
cated TRAF proteins in the activation of NF-B. For ex-
ample, overexpression of TRAF2 or 6 activates NF-B,
and expression of dominant negative TRAF proteins
blocks NF-B activation (Arch et al. 1998). Moreover,
TRAF6 knockout mice exhibit defects in IL-1- and LPS-
induced NF-B activation (Lomaga et al. 1999; Naito et
al. 1999). The TRAF proteins all share a common C-
terminal TRAF domain. This domain is further subdi-
vided into two parts, the highly conserved TRAF-C do-
main and the coiled-coil TRAF-N domain. The TRAF
domain is required for interaction with upstream factors
such as IRAK, TRADD, and various receptors. In addi-
tion, the TRAF proteins contain a variable number of
cysteine-rich zinc fingers N-terminal to the TRAF do-
main, and at their very N terminus most TRAF proteins
encode a RING finger motif.
Recently, RING finger domains have been shown to
play a crucial role in several ubiquitin ligase complexes
implicated in a number of biological processes. For ex-
ample, the RING finger-containing protein Rbx1/Roc1 is
an essential component of the SCF ubiquitination com-
plex (Deshaies 1999) and the Cbl RING finger is required
for ubiquitination of receptor tyrosine kinases such as
PDGFR and EGFR. In addition, the TRAF RING finger
appears to be required for activation of NF-B. In the case
of TRAF2 and 5, the RING finger is required for NF-B
activation, and deletion of just the RING creates a domi-
nant negative protein (Arch et al. 1998). By contrast, the
role of the TRAF6 RING finger is less clear. For example,
a number of studies have shown that NF-B activation
induced by overexpression of TRAF6 does not require
the RING domain (e.g., Cao et al. 1996). In contrast, an-
other study shows that mutations in the conserved cys-
teine or histidine residues in the RING finger abolish
TRAF6-mediated NF-B activation (Deng et al. 2000). In
addition, most of the dominant negative TRAF6mutants
studied involve the removal of both the TRAF6 RING
and Zn finger motifs (Cao et al. 1996). Moreover, forced
dimerization of the RING and Zn finger domains, from
either TRAF2 or TRAF6, activates signaling (Baud et al.
1999). However, Kobayashi et al. (2001) recently showed
that the RING finger of TRAF6 is not absolutely required
for IL-1– and LPS-mediated NF-B activation in MEFs
(Kobayashi et al. 2001). Taken together these experi-
ments suggest that TRAF6 may have both RING finger-
dependent and -independent (Zn finger-dependent)
mechanisms to activate NF-B.
An important breakthrough in understanding the
mechanisms of TRAF6-dependent activation of NF-B
was recently provided by Chen and colleagues. These
investigators established an in vitro system for activat-
ing the IKK// complex in response to the addition of
TRAF6 (Deng et al. 2000). Biochemical fractionation
studies identified two essential activities, called TRIKA
1 and 2, which are required for TRAF6-induced IKK ac-
tivation. TRIKA 1 consists of a heterodimer of two
ubiquination proteins called Ubc13 and Uev1A. Strik-
ingly, these Ubc molecules were shown to catalyze the
nonclassical ubiquitination of protein substrates, form-
ing ubiquitin chains extended on lysine 63 instead of the
usual lysine 48 of ubiquitin. In the classical ubiquitin
system, polyubiquitination of a substrate protein leads
to its proteasome-mediated degradation. However, non-
classical ubiquitin chains, linked through lysine 63, do
not lead to proteasome mediated degradation (Deng et al.
2000). Rather, this ubiquitination is thought to play a
regulatory role, similar to that observed with the ubiq-
uitin-like molecules Nedd8 and Sumo (Yeh et al. 2000).
Thus, TRAF6-mediated IKK activation requires ubiqui-
tination, but not the proteasome (Deng et al. 2000). Ad-
ditional studies showed that TRAF6 functions as part of
an unique E3 complex, with Ubc13 and Uev1A, and that
TRAF6 itself is the target of ubiquitination (Wang et al.
2001). Remarkably, IL-1-, TNF-, and TRAF2-mediated
NF-B activation were all blocked by expression of domi-
nant negative, catalytically inactive Ubc13 (Deng et al.
2000). This exciting finding clearly establishes TRAF6,
and the TRAF family members in general, as ubiquitin
ligase components required in NF-B signaling path-
ways. These findings also explain the puzzling observa-
tion that the partially purified unactivated IKK complex
can be activated by ubiquitination in vitro (Chen et al.
1996).
TRIKA 2, the second activity required for TRAF6-me-
diated IKK activation in vitro, was found to consist of a
complex of the MAP3K TAK1, and the associated pro-
teins TAB1 and TAB2. Furthermore, this TAK1 complex
was shown to be activated by association with K63-ubiq-
uitinated TRAF6. Once activated TAK1 can directly
phosophorylate IKK and MKK6, leading to the activa-
tion of both the JNK/p38 and NF-B signaling pathways
(Wang et al. 2001). Thus, it appears that TAK1 is the
critical IKK-kinase in the IL-1 and TLR signaling path-
ways. This conclusion is consistent with earlier work on
TAK1 showing that dominant negative TAK1 inhibits
IL-1 signaling and that in response to IL-1 TAB2 trans-
locates from the membrane to the cytoplasm where it
associates with TAK1 (Ninomiya-Tsuji et al. 1999;
Takaesu et al. 2000, 2001). In fact, Matsumoto and col-
leagues have previously demonstrated the IL-1-depen-
dent formation of a TAK1/TAB1/TAB2/TRAF6 complex
with endogenous proteins (Takaesu et al. 2000).
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This ubiqutination/TAK1 pathway may also play a
critical role in Drosophila immunity, as the Drosophila
TAK1 homolog, dTAK1, is critical for insect innate im-
munity. Lemaitre and colleagues isolated dTAK1 in a
genetic screen for mutants defective in the IKK- and Rel-
ish-dependent antibacterial signaling pathway (Vidal et
al. 2001). The dTAK1 protein functions downstream of
IMD adaptor protein, but upstream of the DmIKK com-
plex (Vidal et al. 2001). Furthermore, recent unpublished
experiments using RNAi revealed that the Drosophila
homologs of Ubc13 and Uev1A, bendless and dUev1A,
respectively, function in the insect antibacterial signal-
ing pathway (R. Zhou, N. Silverman, Z. Chen, and T.
Maniatis, unpubl.). This suggests that a similar ubiqui-
tin-dependent pathway may be involved in the activa-
tion of the Drosophila IKK complex through dTAK1.
However, a clear picture for the function of Drosophila
TRAF proteins has not been obtained. Analysis of the
Drosophila genome sequence has identified three TRAF
homologs. dTRAF1 is most similar to human TRAF4 but
does not contain a RING finger (Liu et al. 1999; Zapata et
al. 2000). Another, dTRAF2, is most similar to human
TRAF6 and contains a RING finger. The third Dro-
sophila TRAF is poorly characterized but does not appear
to encode either a RING finger or zinc finger motif
(Grech et al. 2000). To date none of the Drosophila
TRAFs have been shown to be involved in either of the
Drosophila immune signaling pathways. Thus, the
RING finger-containing protein that is predicted to be
involved in the ubiquitin-dependent LPS-stimulated ac-
tivation of dTAK1 and subsequent DmIKK activation re-
mains unidentified.
Atypical PKCs
Other potential components of the IL-1/LPS and TNF
signaling pathways include the atypical PKCs,  and ,
and their associated adapter protein p62 (for review, see
Moscat and Diaz-Meco 2000). Inhibition of the aPKCs or
p62, by dominant negative or antisense RNA treatment,
respectively, inhibits IL-1 and TNF signaling. IL-1-in-
duced interactions have been demonstrated between en-
dogenous TRAF6 and p62, and TNF has been shown to
induce an association of aPKCs and p62 with RIP and the
IKK complex assembled at the activated TNFRI. Further-
more, the PKC has been shown to phosphorylate IKK
on serines 177 and 181, within the activation loop, lead-
ing to IKK but not IKK activation. This suggests that
aPKCs may also serve as IKK-kinases (Moscat and Diaz-
Meco 2000). However, these cell culture results have yet
to be verified in vivo and it is not yet clear how the
aPKCs function relative to other putative IKK-kinases
such as MEKK3 and TAK1.
Caspases
Interestingly, the Drosophila caspase protease Dredd is
also required in the antibacterial signaling pathway. In
fact, dredd mutants are unable to cleave Relish (Sto¨ven
et al. 2000) and to activate antibacterial peptide gene
expression in response to infection (Elrod-Erickson et al.
2000; Leulier et al. 2000). In addition, the specific
caspase inhibitor zVAD-fmk is a potent inhibitor of LPS-
stimulated Relish cleavage and antibacterial peptide
gene expression inDrosophila cell culture (N. Silverman
and T. Maniatis, unpubl.). Dredd is an apical caspase
with an extended, death effector domain (DED) contain-
ing pro-domain. Although overexpression of a Dredd iso-
form can cause programmed cell death in cell culture,
the role of Dredd in programmed cell death in vivo re-
mains uncertain (Chen et al. 1998; Rodriguez et al. 1999).
Interestingly, the linker region of Relish, which connects
the RHD and C-terminal IB-like domain, contains a po-
tential caspase cleavage site (LQHDG). These observa-
tions suggest a model in which LPS activates the Dro-
sophila IKK/ complex, which in turn phosphorylates
Relish. The modified Relish protein would then be rec-
ognized and cleaved by Dredd (Fig. 2). However, we have
been unable to cleave phosphorylated Relish in vitro
with recombinant Dredd (P. Chen, N. Silverman, T. Ma-
niatis, J. Abrams, unpubl.). Therefore, other models must
be considered. For example, it was proposed that Dredd
may function similarly to caspase 1, or ICE (Fantuzzi and
Dinarello 1999), to cleave and activate a cytokine-like
signaling molecule that is responsible for transmitting a
signal from the site of infection to the fat body (Elrod-
Erickson et al. 2000).
Another possibility is suggested by the recent charac-
terization of Drosophila FADD (Fas associated death do-
main) homolog, which contains a death domain and a
DED. dFADD was shown to interact strongly and spe-
cifically with Dredd via a homotypic DED domain inter-
action (Hu and Yang 2000). Although the role of dFADD
in immunity has yet to be demonstrated, it is reasonable
to propose that dFADD may be involved in the antibac-
terial signaling pathway. For example, dFADD may in-
teract with IMD via its death domain while contacting
Dredd via its DED domain. In this way, Dredd may be
connected to and activated by the LPS receptor. Analo-
gous to other caspase pathways, activated Dredd could
then cleave and activate an effector caspase, which
would then cleave phosphorylated Relish. In this model,
the DmIKK complex and Dredd would function in par-
allel pathways, both of which are downstream of the LPS
receptor and required for signal-induced Relish activa-
tion (Fig. 2).
In mammals, the classical NF-B signaling pathways
are not known to require any caspase mediated cleavage
events. In fact the caspase inhibitor zVAD-fmk potenti-
ates LPS signaling in primary murine macrophages (P.
Murray, N. Silverman, and T. Maniatis, unpubl.). How-
ever, the recent discovery of a human paracaspase sug-
gests that there may be some similarity between Dro-
sophila Relish activation and NF-B activation in hu-
mans. By using reiterative searches and threading
algorithms, comparing the similarities in the sequence
and structure of mammalian caspases and a bacterial
cysteine protease known as Gingpain R (Eichinger et al.
1999), Dixit and colleagues were able to identify several
NF-B and innate immune signaling pathways
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new caspase related proteases in a number of genomes
including one in humans. They termed these newly
identified genes paracaspases (Uren et al. 2000). Para-
caspases share some structural similarity to the classic
caspases but are in a separate subgroup and are easily
distinguishable from the classic caspases. The human
paracaspase gene is associated with translocations found
in patients with MALT lymphoma. This translocation
fuses the BIR domains of IAP-2 to the catalytic domain of
the human paracaspase gene. Expression of these IAP–
paracaspase fusion genes causes the activation of NF-B
(Uren et al. 2000). This activation requires the proteo-
lytic activity of the paracaspase. Also, the human para-
caspase interacts with Bcl10, a well-known activator of
NF-B. Interestingly, Bcl10 is associated with a different
translocation also found in MALT lymphoma. In fact,
both paracaspase and Bcl10 translocations, t(11;18) and
t(1;14), are required for MALT lymphoma pathogenesis.
Another group demonstrated that forced dimerization of
the paracaspase catalytic domain potently activates NF-
B (Lucas et al. 2001). These findings suggest that un-
identified stimuli may activate NF-B through a Bcl10
and a paracaspase-dependent signaling pathway. The
substrates and the substrate specificity of human para-
caspase are unknown at this time.
Conclusions
Comparison of the Drosophila and mammalian innate
immune signaling pathways has identified both similari-
ties and differences. For example, in both mammals and
insects, the innate immune response is activated by
similar pathogen-derived substances such as LPS or pep-
tido-glycans. Intracellular signaling pathways that are
activated by the Toll family of receptors lead to the ac-
tivation of NF-B, in both insects and mammals. In both
systems NF-B is required for the induction of antimi-
crobial effector mechanisms such as complement acti-
vation, antimicrobial peptide gene expression, and acti-
vation of phagocytosis. A major difference is that activa-
tion of the mammalian innate system leads to
expression of costimulatory molecules and the subse-
quent activation of the adaptive immune response.
Other differences include the mechanisms of immune
recognition; mammals appear to use the TLRs and their
LRR ectodomains to recognize a large array of microbial
pathogens whereas the mechanisms used by insects re-
main unclear. Also, detailed analysis of the signaling
pathways downstream of these receptors reveals impor-
tant differences. For example, insects activate the NF-B
precursor Relish by IKK- and caspase-dependent endo-
proteolytic cleavage. On the other hand, mammalian
NF-Bs are activated by the proteasome-mediated de-
struction of IB proteins, and/or the proteasome-medi-
ated degradation of the C-terminal inhibitory domain of
NF-B precursors p100 and p105. In both systems, it is
clear that the NF-B proteins are themselves activated,
probably by direct phosphorylation. Comparing the simi-
larities and differences between mammals and insects
should continue to provide important insights into the
role of NF-B in the innate immune response.
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